Nasdaq Etf Technical Analysis

IBB
 Etf
  

USD 122.81  2.64  2.20%   

As of the 5th of July, Nasdaq Biotechnology secures the risk adjusted performance of (0.08), and Mean Deviation of 1.78. Nasdaq Biotechnology Ishares technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the etf's future prices. Strictly speaking, you can use this information to find out if the etf will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed nineteen technical drivers for Nasdaq Biotechnology, which can be compared to its peers in the industry. Please verify Nasdaq Biotechnology jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Nasdaq Biotechnology Ishares is priced some-what accurately, providing market reflects its recent price of 122.81 per share.
  
Refresh

Nasdaq Biotechnology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nasdaq, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Nasdaq
Nasdaq Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Nasdaq Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Nasdaq Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Nasdaq Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Nasdaq Biotechnology Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nasdaq Biotechnology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
.

Nasdaq Biotechnology Trend Analysis

Use this graph to draw trend lines for Nasdaq Biotechnology Ishares. You can use it to identify possible trend reversals for Nasdaq Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nasdaq Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Nasdaq Biotechnology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Nasdaq Biotechnology Ishares applied against its price change over selected period. The best fit line has a slop of   -0.24  , which may imply that the returns on investment in Nasdaq Biotechnology Ishares will continue to fail. It has 122 observation points and a regression sum of squares at 2241.07, which is the sum of squared deviations for the predicted Nasdaq Biotechnology price change compared to its average price change.

About Nasdaq Biotechnology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nasdaq Biotechnology Ishares on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nasdaq Biotechnology Ishares based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Nasdaq Biotechnology stock first instead of the macroeconomic environment surrounding Nasdaq Biotechnology. By analyzing Nasdaq Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nasdaq Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nasdaq Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.

Nasdaq Biotechnology July 5, 2022 Technical Indicators

Most technical analysis of Nasdaq help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nasdaq from various momentum indicators to cycle indicators. When you analyze Nasdaq charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Nasdaq Biotechnology One Year Return

Based on the recorded statements, Nasdaq Biotechnology Ishares has an One Year Return of -27.83%. This is 558.48% lower than that of the iShares family and 214.46% lower than that of the Health category. The one year return for all United States etfs is notably higher than that of the company.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Nasdaq Biotechnology July 5, 2022 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Nasdaq stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Please see Risk vs Return Analysis. Note that the Nasdaq Biotechnology information on this page should be used as a complementary analysis to other Nasdaq Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Nasdaq Etf analysis

When running Nasdaq Biotechnology price analysis, check to measure Nasdaq Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasdaq Biotechnology is operating at the current time. Most of Nasdaq Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nasdaq Biotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nasdaq Biotechnology's price. Additionally, you may evaluate how the addition of Nasdaq Biotechnology to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
The market value of Nasdaq Biotechnology is measured differently than its book value, which is the value of Nasdaq that is recorded on the company's balance sheet. Investors also form their own opinion of Nasdaq Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Nasdaq Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nasdaq Biotechnology's market value can be influenced by many factors that don't directly affect Nasdaq Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nasdaq Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine Nasdaq Biotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nasdaq Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.